NeuroDerm Company

NeuroDerm is a clinical-stage pharmaceutical company developing next-generation treatments for central nervous system (CNS) disorders that will make a clinically meaningful difference in patients’ lives. NeuroDerm’s technology enables new routes of administration for existing drugs that overcome their current deficiencies and achieve enhanced clinical efficacy.
Technology: Others
Industry: Regenerative Medicine
Headquarters: Rehovot, Israel
Founded Date: 6-25
Employees Number: 11-50
Funding Status: M&A
Total Funding: $18.5M
Estimated Revenue: Less than $1M

Visit Website
Register and Claim Ownership